Human Interleukin-2-Activated Adherent Natural Killer Cells Recognize a Conserved Antigen Found on Tumor Cells and Protozoan Parasites

Natural Immunity

Volumn 15, Issue 6, 1996, Pages 269-284

  Weisman, Ziva ^a   Evans, Donald L ^b   Jaso Friedmann, Liliana ^c  

^a KAPLAN HOSPITAL   (Israel)

^b UNIVERSITY OF GEORGIA   (United States)

^c NONE

Author keywords

Adherent lymphokine activated killer cells; Antigen specificity; Cytotoxicity; Natural killer cells; Synthetic peptides

Indexed keywords

INTERLEUKIN 2; MONOCLONAL ANTIBODY; PARASITE ANTIGEN; TUMOR ANTIGEN;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CONJUGATION; CYTOTOXICITY; HUMAN; HUMAN CELL; NATURAL KILLER CELL; NORMAL HUMAN; RECEPTOR OCCUPANCY; TETRAHYMENA PYRIFORMIS;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, NEOPLASM; ANTIGENS, PROTOZOAN; BINDING SITES; CELL ADHESION; CONSERVED SEQUENCE; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-2; KILLER CELLS, LYMPHOKINE-ACTIVATED; PEPTIDES; PHENOTYPE; PLASTICS;

EID: 0030318885     PISSN: 10188916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Ferrini S, Cambiaggi A, Meazza R, Sforzini S, Marciano S, Mingari MC, Moretta L: T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur J Immunol 1994;24:2294-2296.
2. Yokoyama WM: Hybrid resistance and the Ly-49 family of natural killer cell receptors. J Exp Med 1995; 182:273-277.
3. Salcedo M, Hoglund P, Ljunggren H-G: Natural killer cell interaction with murine allogeneic MHC class I molecules. Transplantation 1995; 60:281-286.
4. Cella M, Longo A, Ferrara GB, Strominger JL, Colonna M: NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med 1995;180:1235-1242.
5. 2-microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants. J Immunol 1990;145:380-386.
6. Gronberg A, Ferm MT, Ng J, Reynolds CW, Ortaldo JR: IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes. J Immunol 1988;140:4397-4402.
7. Leiden JM, Karpinski BA, Gottschalk L, Kornbluth J: Susceptibility of NK mediated cytolysis is independent of the level of target cell class I HLA expression. J Immunol 1989;142:2140.
8. Storkus WJ, Salter RD, Alexander J: Class I-induced resistance to natural killing: Identification of non-permissive residues in HLA-A2. Proc Natl Acad Sci USA 1991;88:5989.
9. Hamprecht K, Steinmassi M: Low-dose human cytomegalovirus infection of human fibroblast cultures induces lymphokine-activated killer cell resistance: Interferon-beta-mediated target cell protection does not correlate with up-regulation of HLA class I surface molecules. Immunology 1994;82:171.
10. Correa I, Corral L, Raulet DH: Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells. Eur J Immunol 1994;24:1323.
11. Kim M, Duty L, Herberman R, Gorelik E: Divergent effects of H-2K and H-2D genes on sensitivity of BL6 melanoma cells to NK cells or TNF-mediated cytotoxicity. Cell Immunol 1994;155:358.
12. Liu JH, Wei S, Blanchard DK, Djieu JY: Restoration of lytic function in a human natural killer cell line by gene transfection. Cell Immunol 1994;156:24.
13. Jiang YZ, Couriel D, Mavroudis DA, Lewalle P, Malkovska V, Hensel NF, Dermime S, Molldrem J, Barrett AJ: Interaction of natural killer cells with MHC class II: Reversal of HLA-DR-mediated protection of K562 transfectant from natural killer cell-mediated cytolysis by brefeldin-A. Immunology 1996;87: 481-486.
14. Lobo PI, Patel HC: A novel role for MHC class II antigens: Evidence implicating a protective effect on tumour cells against cytotoxicity by NK and LAK cells. Immunology 1994;83:240-244.
15. Hatcher FM, Kuhn RE: Destruction of Trypanosoma cruzi by natural killer cells. Science 1982;218:295-297.
16. Hauser WE, Tsai B: Acute Toxoplasma infection of mice induces spleen NK cells that are cytotoxic for T. gondii in vitro. J Immunol 1986;136:313-323.
17. Dannemann BR, Morris BA, Araujo FG, Remington JS: Assessment of human natural killer and lymphokine-activated killer cell cytotoxicity against Toxoplasma gondii trophozoites and brain cysts. J Immunol 1989;143:2684-2691.
18. Solomon JB, Forbes MG, Solomon GRA: A possible mechanism for natural killer cells in providing protection against Plasmodium berghei in early stages on infection. Immunol Lett 1985;9:349-353.
19. Orago ASS, Facer CA: Cytotoxicity of human natural killer (NK) cell subsets for Plasmodium falciparum erythrocytic schizonts: Stimulation by cytokines and inhibition by neomycin. Clin Exp Immunol 1991;86: 22-28.
20. Romero P: Malaria vaccines. Curr Opin Immunol 1992;4:432-441.
21. Henzel FT, Sadick MD, Mutha SS, Locksley RM: Production of interferon gamma, interleukin-4 and interleukin-10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci USA 1991;88:7011-7019.
22. Rachamim N, Jaffe CL: Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis. J Immunol 1993;150:2322-2331.
23. Capron A, Dessaint JP, Caparon M, Ouma JH, Butterworth AE: Immunity to schistosomes: Progress toward vaccine. Science 1987;238: 1065-1068.
24. Richter D, Reynolds SR, Harn DA: Candidate vaccine antigens that stimulate the cellular immune response of mice vaccinated with irradiated cercariae of Schistosoma mansoni. J Immunol 1993;151:256-264.
25. Subauste CS, Remington JS: Immunity ot Toxoplasma gondii. Curr Opin Immunol 1993;5:532-537.
26. Mineo JR, McLeod R, Mack D, Smith J, Khan A, Ely KH, Kasper LH: Antibodies to Toxoplasma gondii major surface protein (SAG-1, p30) inhibit infection of host cells and are produced in murine intestine after peroral infection. J Immunol 1993;150:3951-3956.
27. Graves SS, Evans DL, Cobb D, Dawe DL: Nonspecific cytotoxic cells in fish (Ictalurus punctatus). I. Optimum requirements for target cell lysis. Dev Comp Immunol 1984; 8:293-302.
28. Evans DL, Graves SS, Cobb D, Dawe DL: Nonspecific cytotoxic cells in fish (Ictalurus punctatus). II. Parameters of target cell lysis and specificity. Dev Comp Immunol 1984;8:303-312.
29. Evans DL, Graves SS, Blazer VS, Dawe DL, Gratzek JB: Immunoregulation of fish nonspecific cytotoxic cell activity by retinolacetate but not poly I:C. Comp Immunol Microbiol Infect Dis 1984;7:91-100.
30. Evans DL, Hogan KT, Graves SS, Carlson RL, Floyd E, Dawe DL: Nonspecific cytotoxic cells in fish (Ictalurus punctatus). Biophysical and biochemical properties affecting cytolysis. Dev Comp Immunol 1984;8:599-610.
31. Evans DL, Carlson RL, Graves SS, Hogan KT: Nonspecific cytotoxic cells in fish (Ictalurus punctatus). IV. Target cell binding and recycling capacity. Dev Comp Immunol 1984;8:823-833.
32. Evans DL, Gratzek JB: Immune defense mechanisms in fish to protozoan and helminth infections. Am Zoologist 1989;29:408-418.
33. Evans DL, Cooper EL: Natural killer cells in ectothermic vertebrates. Bioscience 1990;40:745-749.
34. Evans DL, McKinney EC: Phylogeny of cytotoxic cells; in Warr GW, Cohen N (eds): Phylogenesis of Immune Functions. Boca Raton, CRC Press, 1990, pp 215-239.
35. Evans DL, Jaso-Friedmann L: Non-specific cytotoxic cells as effectors of immunity in fish. Ann Rev Fish Dis 1992;2:109-121.
36. Graves SS, Evans DL, Dawe DL: Antiprotozoan activity of nonspecific cytotoxic cells (NCC) from the channel catfish (Ictalurus punctatus). J Immunol 1985;134:78-85.
37. Graves SS, Evans DL, Dawe DL: Mobilization and activation of nonspecific cytotoxic cells (NCC) in the channel catfish (Ictalurus punctatus) infected with Ichthyophthirius multifiliis. Comp Immunol Microbiol Infect Dis 1985;8:43-51.
38. Jaso-Friedmann L, Leary JH III, McGraw RA, Evans DL: Molecular characterization of a protozoan parasite target antigen recognized by nonspecific cytotoxic cells. Cell Immunol, in press.
39. Evans DL, Leary JH III, Weisman Z, Warren J, Jaso-Friedmann L: Mapping of the epitope recognized by nonspecific cytotoxic cells: Determination of the fine specificity using synthetic peptides. Scand J Immunol 1996;43:556-565.
40. Jaso-Friedmann L, Leary JH III, Weisman Z, Evans DL: Activation of nonspecific cytotoxic cells with a multiple antigenic peptide: Specificity and requirements for receptor crosslinkage. Cell Immunol 1996; 170:195-201.
41. Friedmann L, Evans DL, Grant CC, St. John A, Harris DT, Koren HS: Characterization by monoclonal antibodies of a target cell antigen complex recognized by nonspecific cytotoxic cells. J Immunol 1988;141: 2861-2868.
42. Harris DT, Koren HS, Devlin RB, Jaso-Friedmann L, Evans DL: Analysis of a natural killer cell antigen receptor. Proc 5th Int NK Workshop; in Aedes EW, Lopez C (eds): Natural Killer Cells and Host Defense. Basel, Karger, 1988, pp 172-176.
43. Harris DT, Jaso-Friedmann L, Devlin RB, Koren HS, Evans DL: Identification of an evolutionarily conserved natural killer cell antigen receptor/target antigen complex; in Marachalonis J, Reinisch C (eds): Defense Molecules. New York, Liss, 1990, pp 213-227.
44. Harris DT, Jaso-Friedmann L, Devlin RB, McKinnon K, Koren HS, Evans DL: A putative antigen receptor on human NK cells is a signal transducing molecule. Proc 6th Int NK Workshop; in Schmidt RE (ed): Natural Killer Cells: Biology and Clinical Applications. Basel, Karger, 1990, pp 10-12.
45. Leary JH III, Evans DL, Jaso-Friedmann L: Partial amino acid sequence of a novel protozoan parasite antigen that inhibits nonspecific cytotoxic cell activity. Scand J Immunol 1994;40:158-164.